Free Cash Flow Build Up

Relmada Therapeutics, Inc. (RLMD)

$2.94

+0.10 (+3.52%)
Year
A/P
Revenue
EBITDA
EBIT
Tax Rate
EBIAT
Depreciation
Accounts Receivable
Inventories
Accounts Payable
Capital Expenditure
UFCF
WACC
PV UFCF
SUM PV UFCF